Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ReposiTrak | TRAK | Nov 26, 2024 | 23.20 | +2.65 |
Republic Bancorp A | RBCAA | Nov 26, 2024 | 77.07 | -0.98 |
Republic Services | RSG | Nov 26, 2024 | 218.75 | +0.41 |
Research Frontiers | REFR | Nov 26, 2024 | 1.94 | +0.52 |
Research Solutions | RSSS | Nov 26, 2024 | 3.47 | +3.27 |
Reservoir Media | RSVR | Nov 26, 2024 | 9.29 | +1.53 |
ReShape Lifesciences | RSLS | Nov 26, 2024 | 5.68 | -1.22 |
Resideo Technologies | REZI | Nov 26, 2024 | 27.32 | -1.34 |
ResMed | RMD | Nov 26, 2024 | 249.99 | +0.17 |
Resources Connection | RGP | Nov 26, 2024 | 8.44 | -0.59 |
Restaurant Brands International | QSR | Nov 26, 2024 | 69.21 | -0.86 |
Retail Bull 3X Direxion | RETL | Nov 26, 2024 | 11.09 | -4.15 |
Retail ETF Market Vectors | RTH | Nov 26, 2024 | 230.01 | +0.71 |
Retail Opportunity Investments | ROIC | Nov 26, 2024 | 17.41 | +0.06 |
ReTo Eco-Solutions | RETO | Nov 26, 2024 | 0.99 | -0.97 |
Retractable Technologies | RVP | Nov 26, 2024 | 0.61 | -2.54 |
REV Group | REVG | Nov 26, 2024 | 30.85 | -3.44 |
Revance Therapeutics | RVNC | Nov 26, 2024 | 4.02 | +5.79 |
Revelation Biosciences | REVB | Nov 26, 2024 | 0.75 | +0.67 |
Revenueshares Largecap | RWL | Nov 26, 2024 | 103.92 | +0.10 |
Revenueshares Midcap | RWK | Nov 26, 2024 | 125.71 | -0.62 |
Revenueshares Smallcap | RWJ | Nov 26, 2024 | 48.84 | -1.25 |
Revenueshares Ultra Dividend Fund | RDIV | Nov 26, 2024 | 52.60 | -0.25 |
Reviva Pharmaceuticals | RVPH | Nov 26, 2024 | 1.12 | -2.61 |
Revolution Medicines | RVMD | Nov 26, 2024 | 58.63 | +1.97 |
Revolve Group A | RVLV | Nov 26, 2024 | 38.80 | +2.16 |
Revvity | RVTY | Nov 26, 2024 | 115.07 | +0.36 |
REX American Resources | REX | Nov 26, 2024 | 42.95 | -3.76 |
Rexford Industrial Realty | REXR | Nov 26, 2024 | 42.35 | -1.24 |
Rexford Industrial Realty B Pref | REXR-B | Nov 26, 2024 | 22.86 | -0.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.